TysnesOB,StorsteinA. Epidemiology of Parkinson’s disease.?J NeuralTransm(Vienna). 2017;124(8):901-905. doi:10.1007/s00702-017-1686-y January 17, 2022 Read More
Dibble LE, Foreman KB, Addison O, Marcus RL,LaStayoPC. Exercise and medication effects on persons with Parkinson disease across the domains of disability: A randomized clinical trial.JNPT2015;39(2):85-92. January 17, 2022 Read More
DemirciM, Grill S, McShane D, Hallett M. A mismatch between kinesthetic and visual perception in Parkinsons disease.Ann Neurol1997; 41:781-788. January 17, 2022 Read More
Maguire-Zeiss KA,MhyreTR, Federoff HJ. Gazing into the future: Parkinson’s disease gene therapeutics to modify natural history.Exp Neurol2008;209:101-113. January 17, 2022 Read More
AscherioA, Schwarzschild MA. The epidemiology of Parkinsons disease: risk factors and prevention. Lancet 2017;1592):1257-1272. January 17, 2022 Read More
AyanoG. Parkinsons Disease: A Concise Overview of Etiology, Epidemiology, Diagnosis, Comorbidity and Management.J NeurolDisord. 2016;4(6). doi:10.4172/2329-6895.1000298 January 17, 2022 Read More
BeradelliA, Rothwell JC, Thompson PD Hallett M. Pathophysiology of bradykinesia in Parkinsons disease.Brain2001; 134:2131-2146. January 17, 2022 Read More
BloemBR, Marks WJ, Silva de Lima AL, et al. The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinsons disease.BMC Neurol. 2019;19(1):160. doi:10.1186/s12883-019-1394-3 January 17, 2022 Read More
BloemBR, Marks WJ, Silva de Lima AL, et al. The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinsons disease.BMC Neurol. 2019;19(1):160. doi:10.1186/s12883-019-1394-3 January 17, 2022 Read More
BraakH, DelTrediciK,RbU,et al. Staging of brain pathology related to sporadic Parkinsons disease.NeurobiolAging. 2003;24(2):197-211. doi:10.1016/S0197-4580(02)00065-9 January 17, 2022 Read More
